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Abstract
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Dimethylglycine dehydrogenase (DMGDH) is a mammalian mitochondrial enzyme which plays
an important role in the utilization of methyl groups derived from choline. DMGDH is a flavin
containing enzyme which catalyzes the oxidative demethylation of dimethylglycine in vitro with
the formation of sarcosine (N-methylglycine), hydrogen peroxide and formaldehyde. DMGDH
binds tetrahydrofolate (THF) in vivo, which serves as an acceptor of formaldehyde and in the cell
the product of the reaction is 5,10-methylene tetrahydrofolate instead of formaldehyde. To gain
insight into the mechanism of the reaction we solved the crystal structures of the recombinant
mature and precursor forms of rat DMGDH and DMGDH-THF complexes. Both forms of
DMGDH reveal similar kinetic parameters and have the same tertiary structure fold with two
domains formed by N- and C-terminal halves of the protein. The active center is located in the Nterminal domain while the THF binding site is located in the C-terminal domain about 40 Å from
the isoalloxazine ring of FAD. The folate binding site is connected with the enzyme active center
via an intramolecular channel. This suggests the possible transfer of the intermediate imine of
dimethylglycine from the active center to the bound THF where they could react producing a 5,10methylenetetrahydrofolate. Based on the homology of the rat and human DMGDH the structural
basis for the mechanism of inactivation of the human DMGDH by naturally occurring His109Arg
mutation is proposed
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Introduction
DMGDH is a mammalian flavin mitochondrial enzyme (EC 1.5.8.4), which catalyzes the
oxidative demethylation of dimethylglycine (DMG). When this reaction is studied in vitro
the products of reaction are sarcosine, hydrogen peroxide and formaldehyde [1, 2]. In the
cell, the redox partner of DMGDH is an electron-transferring flavoprotein (ETF) [3]. The
demethylation is performed using FAD as electron acceptor which is covalently bound to
His84 (precursor numbering) via a histidyl(N3)-(8α)FAD bond [4]. In the rat this enzyme is
encoded by a nuclear gene and is translated as a precursor protein of 857-aa (molecular mass
of 96 kDa) [5]. Upon transfer into mitochondria the 21-aa N-terminal mitochondrial
targeting peptide is removed by a mitochondrial processing protease [6].
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The physiological role of both the substrate and product of the DMGDH reaction,
dimethylglycine and sarcosine, are not well understood although they are important
intermediates in one-carbon metabolism. Abnormal levels of DMG are associated with a
variety of diseases and DMG has been proposed as therapeutic for specific pathologies [7–
9].
This enzyme was re-discovered in our laboratory as a folate-binding protein [10]. It binds
different forms of folate with the highest affinity for THF. Based on that finding it was
proposed that bound THF serves as a scavenger for the formaldehyde produced during the
course of dimethylglycine demethylation. The mechanism of this process could not be
determined because of the lack of structural data.
We have now solved the crystal structures of the mature and precursor forms of the rat
DMGDH in the presence of THF. Our choice of the rat DMGDH was based on the fact that
this enzyme was much better studied than any other mammalian DMGDH, thus structure/
function relationships can be precisely described.
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Materials and Methods
A recombinant precursor (prDMGDH) and mature (mDMGDH) forms of rat DMGDH
cloned from Mammalian Gene Collection clone (RefSeq BC085697) were expressed in E.
coli. In addition, precursor form of rat DMGDH (prDMGDH-var2) was expressed from the
plasmid provided by Dr. Barile (University of Bari, Italy). In the latter there are six
substitutions in amino acids as explained below. Cloning, proteins expression and
purification are described in Supplementary Data.
Activity Assay
DMGDH steady state kinetics was studied by using ferricenium hexafluorophosphate
(Fc+PF6−) [11]. This synthetic one-electron acceptor changes its spectrum upon reduction to
ferrocene by FADH2. An assay was carried out in a 150 μl reaction mixture containing 100
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mM HEPES pH 7.5, 35 nM of enzyme, 200 μM of Fc+PF6− and 0.05–50 mM of N,Ndimethylglycine at 25°C. The reduction of Fc+PF6− was followed by the decrease of
absorbance at 300 nm using a Shimadzu 2540 UV/visible spectrophotometer equipped with
a thermostated cell holder. The DMGDH activity was calculated by moles of reduced
Fc+PF6− which was calculated based on ε300=4300 M−1cm−1 [11] taking into account that 2
moles of Fc+PF6− are reduced per mole of enzyme. Measurements were made in duplicate.
Kinetic data were analyzed by the Michaelis-Menten equation using GraphPad Prism 5
software.
Crystallization
The mature form of DMGDH was crystallized using 0.2 M K/Na-tartrate-20% PEG 3350 as
a precipitant. The protein solution in 20 mM HEPES pH 7.5–25 mM NaCl- 2 mM DTT with
protein concentration of 12–15 mg/ml was mixed with precipitant.
The precursor DMGDHvar-2 was crystallized using 0.2 M NaSCN-20% PEG 3350-0.1 M
Tris pH 7.5 as precipitant. The protein solution in 20 mM HEPES pH 7.5–25 mM NaCl- 2
mM DTT with a protein concentration of 12–15 mg/ml was mixed with precipitant at 20°C.
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Folate was introduced into the crystals by the soaking method in the precipitant solutions
used for crystallization supplemented with 25 mM DTT and 5–10 mM THF for three hours
at 20°C. After soaking crystals were flash-frozen in liquid nitrogen and used for the X-Ray
data collection. THF concentration was determined by absorbance at the maximum at 298
nm with an extinction coefficient at pH 7.0 of 29.1 mM−1cm−1.
Data collection and structure solving
Diffraction data were collected at 100 K at LS-CAT beamline 21-F, Advanced Photon
Source, Argonne National Laboratory using Mar225 CCD detector. Data were processed
and scaled using HKL2000 package [12]. Data collection and data processing statistics are
summarized in Table 1.
Crystal structure determination
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The first and superior data set was collected for the precursor DMGDHvar-2-folate crystal
and the crystal structure was determined for that protein. The structure was solved by
Molecular Replacement (MR) with MOLREP [13]. A monomer of bacterial dimethylglycine
oxidase (PDB accession code 1PJ5) served as the search model. Two protein molecules
were located in the asymmetric unit. The positioned MR model was refined using the
maximum likelihood refinement in REFMAC [13] with the TLS parameters generated by
the TLSMD server [14]. Coot [15] was used for model building throughout the refinement.
The final model consists of protein residues 38–860 (monomer A), 38–861 (monomer B),
two covalently bound FAD molecules, two folate molecules, 8 thiocyanate anions and 721
water molecules. Alternate conformations have been built for protein residues K100, N693
(monomer A) and K100 (monomer B).
The refined DMGDH-var2-folate structure at 1.85 Å resolution (with deletion of folate and
water molecules from the model) was used to locate MR solutions in the mDMGDH and
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mDMGDH-folate data sets. Model building and refinement of these structures were done in
a similar way as described for the prDMGDHvar-2-folate structure. Data refinement
statistics are listed in Table 1. The data were deposited to Protein Data Bank with PDB IDs
4P9S, 4PAA and 4PAB for mature DMGDH, mature DMGDH-THF and precursor
DMGDH-THF structures respectively.

Results
Protein expression and activity
The expression and purification protocol we used resulted in preparation of DMGDH
precursor and mature forms completely reconstituted with FAD. Reconstitution efficiency
was determined by the ratio of A275/A460. This parameter for native DMGDH prepared
from rat liver mitochondria is 1.73 [16]. Our preparations routinely have absorbance ratios
of 1.71–1.75.
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The main kinetic parameters are similar for both forms of DMGDH: there are only modest
differences among the forms assayed. The precursor form is a slower enzyme with kcat value
(1.43–1.48 sec−1), two fold lower compared to the mature form (2.65 sec−1). Interestingly,
the Km value for mature form (580 mM) is lower than precursor DMGDH (760 mM) but
higher than prDMGDH-var2 (460 mM). In the dimethylglycine concentrations used (1–50
mM) our samples were characterized by single Km values as shown by transformation of
standard velocity/substrate dependence into an Eadie-Hofstee plot (Supplementary figure 1
and Table 2).
Overall structure
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A search of structures deposited in databank reveals only the bacterial DMGO [17–19] as a
protein with structural similarity to full length DMGDH (Supplemental figure 2). RMS
deviations over 742 structurally equivalent CA atoms (PDB code 3GSI) are 1.88 Å. As in
DMGO, DMGDH consists of two principle domains: the FAD binding domain (N-terminus
domain, residues 1–450) and the folate binding domain (C-terminus domain, 451–860) as
shown in Fig. 1A. The six amino acid residues in which correct and variant-2 sequences are
different (Ala204Val, Thr402Lys, Asn746Asp, Asn774Asp, Ile267Val and Glu509Arg) are
not likely to interfere with folding. RMS deviation between all three DMGDH structures
described here lie in the 0.14–0.35 Å range. The structures of precursor and mature forms of
DMGDH are equivalent, the discussion reflects this fact.
N-terminus domain
The N-terminal domain is 31 amino acids longer in DMGDH in comparison to the DMGO
molecule. The residues 1–37 are not visible in electron density, consistent with a lack of
order. Alignment of the N-terminal domain using the secondary structure matching (SSM)
database [20] showed that the most structurally related protein is the β-subunit of L-proline
dehydrogenase (29% of sequence identity, RMSD of 1.65 Å over the 349 CA atoms). Other
matches include the β-subunit of sarcosine oxidase (24% of sequence identity, RMSD of
1.97 Å over the 349 CA atoms), MTOX (18% of sequence identity, RMSD 2.26 Å over 342
CA atoms), glycine oxidase (23% of sequence identity, RMSD of 2.31 Å over 334 CA
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atoms), D-arginine dehydrogenase (20% of sequence identity, RMSD of 2.62 Å over the 335
CA atoms) and nikD (18% of sequence identity, RMSD of 2.72 Å over 333 CA atoms). The
N-terminus domain could be divided to two subdomains (Fig. 1B). The first one, (FADbinding subdomain) (residues 1–86, 188–258 and 368–450) is represented by a central fivestranded parallel β-sheet surrounded by α-helices on one side and three-stranded antiparallel
β-sheet on the other side. Such nucleotide-binding fold is observed in enzymes belonging to
the glutathione reductase family of enzymes. N-terminal domain covalently binds cofactor
FAD through His84.
The second domain, often called as “catalytic” domain in proteins with similar fold (residues
87–187 and 259–367), consists of a mixed, mostly antiparallel eight β-sheet surrounded by
four α-helices. This domain wraps around the catalytic site.
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The FAD molecule adopts an elongated conformation with the adenine and isoalloxazine
moieties distal from each other, similar to the conformation observed in a number of other
flavoproteins. The flavin isoalloxazine ring binds in the crevice between the two subdomains
and is buried inside of the protein. In contrast, the adenine moiety is exposed to the solvent.
FAD binding is stabilized by numerous hydrogen bonds in addition to the covalent linkage
through histidyl(N3)-(8α)FAD (Fig. 1C). The N-3 of the flavin isoalloxazine ring makes
hydrogen bond to the carbonyl oxygen of Ile88, O-4 is hydrogen bonded to the main chain
NH of Ile88, O-2 makes H-bonds to the main chain NHs of Ile394 and Ile395 and N-5 is
hydrogen bonded to the main chain NH of Ala86. The ribityl phosphate moiety is stabilized
through hydrogen bonding interactions between O4′ and OG of Thr82, O3′ and the carbonyl
oxygen of Phe390 and the main chain NH of Gly393. Hydrophobic interactions with protein
involve Tyr392, Ile365, Tyr265, Ile394, His263 and Ala85. The adenine ring sits in the
hydrophobic pocket formed by Val212, Ile48, Trp244 and Ala241. Interactions of the
adenine ring with the protein involve hydrogen bonds between N-1 and the main chain NH
of Val212, between N-6 and the carbonyl oxygen of Val212 and between N-3 and the main
chain NH of Lys74. Additional interactions between FAD and protein include H-bonds
between O2B of the ribose ring and O2E of Glu73, O3B of the ribose ring and O1E of
Glu73, O1A and the main chain NH of Ser81, O2A and the main chain NH and OG of
Thr82.
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Folate binding domain
Alignment of the folate binding domain showed that the same fold is observed in the Tprotein of the glycine cleavage system (30% of sequence identity, RMSD of 1.35 Å over
352 CA atoms), aminomethyltransferase (31% of sequence identity, RMSD of 1.65 Å over
349 CA atoms) and dimethylsulfoniopropionate-dependent demethylase (19% of sequence
identity, RMSD of 1.78 Å over 355 CA atoms). The folate binding domain of DMGDH can
be divided into three subdomains positioned in a cloverleaf-like arrangement as in the
DMGO crystal structure (Fig. 2A). Domain 1 (residues 460–530 and 620–721) contains a
single Greek Key motif surrounded by α-helices. Domain 2 (residues 531–619 and 722–
763) is represented by five-stranded antiparallel β-sheet with flanking α-helices. Domain 3
(residues 764–843) forms a distorted jelly roll. The striking feature of the DMGDH
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molecule in comparison to known structures of similar fold is a presence of an additional αhelix at the very end of the C-terminus, protruding into external solvent area.
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The folate molecule is bound in the central cavity of the folate-binding domain (Fig. 2B)
with the pterin ring located in the center of the cavity with the glutamate tail exposed to the
external solvent. The bound folate is found in the bent conformation as observed in the
DMGO-folate complex [18, 19]. Surprisingly, binding of folate does not induce any
conformational changes in the protein molecule. There are basically no differences in the
conformation of amino acids lining the folate binding site between the folate bound and
folate free forms of DMGDH. The RMSDs between the two structures lie in the 0.14–0.28
Å range for two independent molecules. The N-2 of the pterin ring of folate makes hydrogen
bonds with OH of Tyr678 and OE1 of Glu676 (Fig. 2C). N-3 is hydrogen bonded to OE2 of
Glu676, N-1 to OE1 of Glu573. There is only one H-bond between the glutamate tail of
folate: OE2 to OH of Tyr737. However, the water mediated hydrogen bond to the
“corkscrew” helix OG atom of Thr843 is also observed. Additional stabilizing interactions
include hydrophobic interactions with Ile667, Tyr669, Ile587, Thr575, Ile560, Phe738,
Phe649, Leu650 and Phe717.
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The “corkscrew” α-helix
The crystals which structures described in this work are crystallized in different crystal
forms (Table 1). However, the “corkscrew” α-helix is presented in all crystal forms despite
completely different packing contacts involving the helix. This fact indicates that formation
of the terminal helix is not a packing artifact. The role of the “corkscrew” helix in DMGDH
is unclear. Such a helix does not exist in DMGO and all C-terminus structurally related
proteins, indicating that it is most likely not essential for the catalysis. However, the
“corkscrew” α-helix (Fig. 2B) is positioned next to the folate binding site and there is a
water mediated H-bond between OX1 of glutamate tail of folate and OG of Thr843. More
work must be done to uncover the potential role of the “corkscrew” helix.
Channel connection of the active center and the folate binding site
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The identical reactions catalyzed by rat DMGDH and DMGO from Arthrobacter
globiformis and the similarity of the protein folds of these enzymes suggest that it is most
likely the mechanism of the transfer of the one carbon unit to THF is the same or similar for
both enzymes. For DMGO it was suggested that the intermediate imine from the active
center is channeled to the folate binding site by an intramolecular channel [18, 19]. Analysis
of the crystal structure of DMGDH revealed, indeed, that such a channel filled with
numerous water molecules does exist in the mammalian enzyme. As shown in Fig. 3 a
channel of about 40 Å, connects the enzyme active center with bound FAD and the folate
binding site.

Discussion
The purpose of this work was to obtain a structural basis for the role of THF in the
dimethylglycine demethylation by rat DMGDH since no structure of mammalian enzymes
was solved so far. The DMG demethylation enzymes are important in one-carbon
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metabolism in mammals and prokaryotes. The common feature of the enzymes is that they
bind THF, a scavenger for the otherwise toxic formaldehyde as a product of this reaction.
Previously, the crystal structure of dimethylglycine oxidase from the bacterium Arthrobacter
globiformis, with different forms of folates, was obtained [18, 19]. It was striking to
discover that the folate binding site was localized about 40 Å from the enzyme active center
in the crystal structure of DMGO. Careful analysis of the structure of DMGO allowed the
authors [18, 19] to propose the hypothesis that in the reaction catalyzed by DMGO,
formaldehyde was not formed. They proposed that an intermediate imine formed from
dimethylglycine is channeled from the active center to the THF forming 5,10methyleneTHF and released as a product of the reaction.
Analysis of the structure of rat DMGDH shows that the mechanism of the channeling of an
intermediate imine proposed for DMGO could be applied to DMGDH. A possible channel
from FAD to THF is shown in Fig. 3. We should notice here, that the channeling hypothesis
still needs direct evidence for the existence of intermediates of the reaction of an imine with
THF. This could be a very challenging project due to a potentially very short time of the
existence of such intermediates as was pointed out elsewhere [19].
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The crystal structure of rat DMGDH presented here is a good representation of mammalian
DMGDH due to high similarity of the protein sequences. The human DMGDH precursor
sequence is 91% identical to rat enzyme with one third of the differences located in the first
60 N-terminal parts of the proteins. Therefore the crystal structure of rat DMGDH can be
used in the explanation of the inactivation of the natural His109Arg mutant of human
DMGDH [21]. The authors modeled the mechanism for that inactivation based on the
crystal structure of DMGO from Arthrobacter globiformis. In their model the His109 is
located about 18 Å from the FAD and therefore there is no direct participation in the
formation of active center. Having the rat DMGDH structure solved and almost 100%
similarity with human enzyme in the region of interest we can now propose a more specific
explanation of the effect of His109Arg mutation. The His109 in human DMGDH
corresponds to His102 in the rat enzyme. In rat DMGDH this residue is located on the side
of the helix 101–114 and is positioned toward FAD at a distance of 7.7 Å (Fig. 4). Most
importantly, His102 establishes strong hydrogen bonds with Thr90 and His396 which means
that it participates in creating the active center of the enzyme. This may indicate a strong
interference in the conformation of the active center by replacements of histidine by arginine
in the patient mutated enzyme and, as the result, a loss of activity.
In conclusion, the crystal structure we reported in this work is a necessary basis for the
future studies of the mechanism of participation of the THF in dimethylglycine
dehydrogenase enzymatic demethylation of dimethylglycine as well as in the other similar
enzymes. It should be noted here that in our recently solved structure of lysine specific
histone demethylase LSD1 complexed with tetrahydrofolate [22] the latter is bound in close
proximity to FAD, thus providing another example of the importance of the study of the role
of folate in demethylation.
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dimethylglycine dehydrogenase
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dimethylglycine
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•

DMGDH is an important enzyme in one-carbon metabolism

•

Bound tetrahydrofolate (THF) serves as a scavenger for the formaldehyde
product

•

We solved the crystal structure of DMGDH and DMGDH-THF complex

•

An intramolecular channel connects the active site and the THF binding site

•

A mechanism for human DMGDH inactivation by a natural mutation is
proposed
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Figure 1. A. Stereo view of a monomer of DMGDH
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The N-terminus FAD-binding domain (purple and yellow) and the C-terminus folatebinding domain (red, blue and green) are shown with secondary structure drawing. FAD and
THF molecules are shown as space-filled models.
B. Structure of the N-terminus domain. The FAD binding subdomain is shown in purple,
the “catalytic” subdomain is shown in yellow. FAD molecule is shown as space-filled
model.
C. The FAD binding site. The amino acids from the FAD binding subdomain are shown in
purple while the amino acids from the catalytic subdomain are shown in yellow. Dashed
lines indicate hydrogen bonds. FAD molecule is shown in balls and sticks representation.
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Figure 2. Structure of the folate-binding domain
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A. View of domain in two orientations. The subdomain-1 is shown in red, the subdomain-2
is shown in blue and the subdomain-3 is shown in green. The terminal “corkscrew” α-helix
is shown in grey. Folate molecule is shown as a space-filled model.
B. The stereo view of the folate binding site. The amino acids from the subdomain 1 are
shown in red while the amino acids from the subdomain 2 are shown in blue. Dashed lines
indicate hydrogen bonds. Fo-Fc electron density omit map contoured at 3σ. The folate
molecule is shown in ball and stick representation.
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Figure 3. Intramolecular channel in DMGDH
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The crossection of the DMGDH structure was done by Pymol. FAD and THF are in yellow
color. The possible connection of FAD and THF sites is shown by the yellow line.
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Figure 4. Modeling the position of human His109 in the crystal structure

The interactions of the His102 in rat DMGDH which corresponds to His109 in the sequence
of human DMGDH in the crystal structure.
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Table 1
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Data Collection, Phasing and Refinement Statistics.
DMGDHvar2-folate

mDMGDH - folate

mDMGDH

Wavelength (Å)

0.9787

0.9787

0.9787

Resolution (Å)

1.85

2.25

2.32

Temperature (K)

100

100

100

Space group

P21

P212121

P212121

84.18

84.93

85.21

Cell dimensions
a (Å)
b (Å)

107.22

130.66

131.44

c (Å)

114.47

171.86

171.92

β (°)

92.2
2

2

Number of molecules per asymmetric unit
No. of unique reflections

2
167 803

87 235

75 192

Rpim

3.7 (39.2)

6.1 (29.7)

7.6 (29.8)

Completeness (%)

1,2 (%)

NIH-PA Author Manuscript

96.7 (90.2)

97.1 (90.6)

91.1 (85.5)

Redundancies

5.7 (4.3)

6.7 (5.6)

5.6 (6.0)

I/σ(I)

22.2 (1.5)

11.7 (1.9)

13.7 (2.3)

48.19 – 1.85

40 – 2.26

40 – 2.32

163 455

85 428

73 606

Refinement statistics
Resolution range (Å)
No. of reflections used in refinement

σ cutoff used in refinement
3 (%)

R/Rfree

none

none

none

20.65/23.04

24.08/26.74

25.30/29.48

13 085

12 952

12 952

Number of refined atoms
Protein
Heterogen atoms

178

170

106

Water

721

236

104

Protein

35.8

38.3

31.0

Water

30.5

15.2

16.8

FAD

25.1

16.8

21.3

THG

50.8

30.9

-

Bonds (Å)

0.008

0.007

0.011

Angles (°)

1.288

1.168

1.444

Favored

97.32

97.17

96.44

Outliers

0.12

0.12

0.12

Average B-factors

(Å2)
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R.m.s. deviations

Ramachandran plot (%)

1

Values in parentheses are for the highest-resolution shell.

2

Rpim is a redundancy-independent measure of the quality of intensity measurements.
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Rpim = Σhkl (1/(n − 1))1/2 Σi |Ihkl,i − <Ihkl>|/Σhkl Σi Ihkl,i, where Ihkl,i is the scaled intensity of the ith measurement of reflection h, k, l,
<Ihkl> is the average intensity for that reflection, and n is the redundancy.
3

R = Σ|| Fo | − | Fc ||/Σ|Fo|, where Fo and Fc are the observed and calculated structure factors amplitudes. Rfree is calculated using ~ 2.0 % of

NIH-PA Author Manuscript

reflections omitted from the refinement. The same Rfree set was used in case of mDMGDH·folate and mDMGDH structures because of
isomorphous character of data sets.
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